Valencia Nutrition stock gains 10% after inking manufacturing deal with Virchow Laboratories, here's detailsValencia Nutrition stock gains 10% after inking manufacturing deal with Virchow Laboratories, here's details

Introduction

Leading beverage firm partners with Virchow Laboratories Ltd to manufacture eight juice variants, securing monthly production and improving efficiency at its Hyderabad production facility.

Also Read: Vikran Engineering share price rallies 12% after bags ₹530 Cr power infra orders in Maharashtra

Share price movement of Valencia Nutrition

On April 07, 2026, Valencia Nutrition Ltd opened at ₹56.54, up 10.00% from its previous close of ₹51.40. The stock reached a high of ₹56.54 (10.00%) and a low of ₹56.54. By 11:56 AM, it traded at ₹56.54, a 10.00% increase, with a market cap of ₹97.42 crore.

Valencia Signs Juice Manufacturing Deal

Valencia Beverages and Superwaters P Ltd, a subsidiary of Valencia Nutrition, signed a manufacturing agreement with Virchow Laboratories Ltd. The deal covers 8 juice SKUs including Mango, Guava, and Apple.

The agreement secures a monthly production volume, about 15% of Valencia Beverages Unit II’s capacity in Hyderabad. It aims to improve production efficiency and optimize facility utilization.

Stock performance of Valencia Nutrition for period of 1 week, 6 months, and 1 year

Valencia Nutrition Ltd delivered a 1-week return of 9.36%, a 6-month return of -39.5%, and a 1-year return of 11.7%.

Also Read: Kernex Microsystems stock in focus after winning ₹91 Cr railway Kavach order from BLW

Shareholding pattern of Valencia Nutrition

Particulars	Feb 2026	Dec 2025	Nov 2025
Promoter	64.20%	61.90%	62.50%
FII	0%	0%	0%
DII	0.00%	0.00%	0.00%
Public	35.80%	38.10%	37.50%

About Valencia Nutrition

Valencia Nutrition Ltd (BSE: 542910), incorporated in 2013, develops, manufactures, and distributes nutraceutical products, offering a range of health and nutrition solutions across India.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs